期刊文献+

沐舒坦治疗婴幼儿肺炎临床疗效观察 被引量:14

Observation of clinical effect of mucosolvan in treatment of infants with pneumonia
下载PDF
导出
摘要 目的 :探讨沐舒坦治疗婴幼儿肺炎的临床疗效。方法 :对2003年1月~2004年1月我科收治住院的126例婴幼儿肺炎随机分作治疗组63例和对照组63例 ,两组均采用常规治疗方法 ,而治疗组加沐舒坦15mg静脉滴注 ,每日1次。结果 :治疗组与对照组在住院天数、肺部罗音及痰鸣音消失时间均优于对照组 (P<0 05)。结论 :沐舒坦可明显提高常规抗感染治疗婴幼儿肺炎的疗效。 Objective:To evaluate the clinical effect of mucosolvan in the treatment of infants with pneumonia.Methods:126cases of infantile pneumonia were randomized into two groups:control group and treatment group.Both groups received routine therapy,the treatment group was treated with additional intravenous drip of mucosolvan15mg once a day.Results:There were significant differences between the two groups in the duration of hospitalization,disappear time of pulmonary rale and grunting.Conclusion:Mucosolvan can remarkably improve the effect of routine therapy in the treatment of infants with pneumonia.
出处 《现代医药卫生》 2004年第16期1579-1579,共1页 Journal of Modern Medicine & Health
关键词 沐舒坦 治疗 婴幼儿 肺炎 疗效观察 Infant Mucosolvan Pneumonia
  • 相关文献

参考文献3

二级参考文献15

  • 1[1]Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med, 1998, 92:609-623. 被引量:1
  • 2[2]Teramoto S, Suzuki M, Ohga E, et al. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or with-out chronic obstructive pulmonary diseases. Pharmacology,1999, 59:135-141. 被引量:1
  • 3[3]Gillissen A, Bartling A, Schoen S, et al. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung, 1997, 175:235-242. 被引量:1
  • 4[4]Park NH, Han ES, Lee CS, et al. The inhibitory effect of ambroxol on respiratory burst, de granulation and cytosolic Ca2+ change in degraded immunoglobulin G-activated neutrophils. Pharmacol Toxicol, 1999, 84: 81-87. 被引量:1
  • 5[5]Pfeifer S, Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. EurJ Med Res, 1997, 2:129-132. 被引量:1
  • 6[6]Stettner S, Ledwozyw A. The effect of Ambroxol on bleomycininduced changes in phospholipid composition of rat lung surfactant. Acta Physiol Hung, 1995, 83:181-187. 被引量:1
  • 7[7]Mira E, Benazzo M, De Paoli F, et al. Surfactants of the air-ways. Critical review and personal research. Acta Otorhinolaryngol Ital, 1997, 17(1 Suppl 56):3-16. 被引量:1
  • 8[8]Nemcekova E, Nosalova G, Franova S. Ambroxol and protective reflexes of the respiratory tract. Bratisl Lek Listy, 1998, 99:111-115. 被引量:1
  • 9[9]Tyrakowski T, Greczko Ⅰ, Sedlaczek A, et al. Electrophysiological investigation of the effects of ambroxol on the transepithelial Na + ion transport pathway in airways. Pol J Pharmacol,1998, 50:31-38. 被引量:1
  • 10[10]Tyrakowski T, Sedlaczek A, Greczko Ⅰ, et al. Ambroxol effect on transepithelial electrical potential difference of isolated tracheal wall. Pol J Pharmacol, 1997, 49:53-58. 被引量:1

共引文献341

同被引文献43

引证文献14

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部